TLE5
TLE family member 5
Also known as: AES, GRG5, TLE5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q08117
- Gene
- TLE5
- Ensembl
- ENSG00000104964
- Chromosome
- 19
- Canonical length
- 197 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
The protein encoded by this gene is similar in sequence to the amino terminus of Drosophila enhancer of split groucho, a protein involved in neurogenesis during embryonic development. The encoded protein, which belongs to the groucho/TLE family of proteins, can function as a homooligomer or as a heteroologimer with other family members to dominantly repress the expression of other family member genes. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
197 residues, UniProt reviewed canonical sequence.
>Q08117|TLE5
1 MMFPQSRHSG SSHLPQQLKF TTSDSCDRIK DEFQLLQAQY HSLKLECDKL ASEKSEMQRH
61 YVMYYEMSYG LNIEMHKQAE IVKRLNGICA QVLPYLSQEH QQQVLGAIER AKQVTAPELN
121 SIIRQQLQAH QLSQLQALAL PLTPLPVGLQ PPSLPAVSAG TGLLSLSALG SQAHLSKEDK
181 NGHDGDTHQE DDGEKSDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TLE5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 594 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 594 nTPM
- cerebellum: 589 nTPM
- amygdala: 501 nTPM
- skeletal muscle: 476 nTPM
- heart muscle: 464 nTPM
- hippocampal formation: 421 nTPM
Single-cell type
- extravillous trophoblasts: 538 nCPM
- prostatic club cells: 371 nCPM
- salivary duct cells: 345 nCPM
- prostatic hillock cells: 318 nCPM
- respiratory secretory cells: 308 nCPM
- smooth muscle cells: 306 nCPM
Immune cell
- T-reg: 243 nTPM
- naive CD4 T-cell: 222 nTPM
- memory CD4 T-cell: 170 nTPM
- naive CD8 T-cell: 150 nTPM
- memory CD8 T-cell: 135 nTPM
- gdT-cell: 131 nTPM
Brain region
- cerebral cortex: 441 nTPM
- pons: 390 nTPM
- thalamus: 383 nTPM
- cerebellum: 371 nTPM
- hypothalamus: 349 nTPM
- amygdala: 339 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.94
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of canonical Wnt signaling pathway
- negative regulation of DNA-templated transcription
- negative regulation of gene expression
- negative regulation of response to cytokine stimulus
- negative regulation of transcription by RNA polymerase II
- positive regulation of anoikis
- regulation of growth
- response to interleukin-1
- skeletal system development
- Wnt signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TLE5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TLE5 as an antibody target. Whether an autoantibody or antibody against TLE5 could matter depends on whether native TLE5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TLE5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TLE5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...